Literature DB >> 17536038

18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.

S Györik1, L Ceriani, A Menafoglio, A Gallino, R Wyttenbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17536038      PMCID： PMC2117222          DOI： 10.1136/thx.2006.070805

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  2 in total

1.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Authors:  Shinji Ishimaru; Ichizo Tsujino; Toshiki Takei; Eriko Tsukamoto; Shinji Sakaue; Mitsunori Kamigaki; Naofumi Ito; Hiroshi Ohira; Daisuke Ikeda; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur Heart J       Date:  2005-04-04       Impact factor: 29.983

2.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057
  2 in total
  3 in total

1.  Cardiac sarcoidosis: a challenge to measure disease activity.

Authors:  Ruth G M Keijsers; Fred J Verzijlbergen; Benno J W M Rensing; Jan C Grutters
Journal:  J Nucl Cardiol       Date:  2008-04-08       Impact factor: 5.952

2.  Management of cardiac sarcoidosis in the United States: a Delphi study.

Authors:  Nabeel Y Hamzeh; Frederick S Wamboldt; Howard D Weinberger
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

Review 3.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.